跳至主要内容
临床试验/KCT0004427
KCT0004427招募中未知

Prognostic Scoring System in Brain Hemorrhage Patients: the clinical value of serum magnesium and calcium

Asan Medical Center0 个研究点目标入组 102 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 80(Year)(—)
性别
All

入选标准

  • 1.Age =18 years and = 80 years
  • 2.Acute hemorrhagic stroke patients: traumatic intracerebral or intraventricular hemorrhage (ICH or IVH), spontaneous ICH or IVH, vascular structure related ICH or IVH (AVM, CM), subdural or epidural hematoma (SDH or EDH), tumor bleeding
  • 3.Glasgow Coma Score (GCS): 5-15
  • 4.Operation or non-operation cases
  • 5.Expected ICU stay > 48 hours

排除标准

  • 6.Disease that hypercalcemia may be harmful
  • Subarachnoid hemorrhage (SAH) d/t aneurysm rupture or trauma
  • Moyamoya disease (MMD)
  • Medical disease: AKI, coronary diseases (myocardial infarction), gout, hyperparathyroidism
  • 7.On antiplatelets or anticoagulation agents (aspirin, clopidogrel, cilostazol, heparin, warfarin ?vitamin K antagonist?, DOAC ?Direct Oral Anticoagulants?)
  • 8.Hematologic disorder or thrombocytopenia ( < 50, 000/µL)
  • 9.Post-anoxic coma; status epilepticus without underlying brain injury; central nervous system (CNS) infections (community-acquired; hospital-acquired; ventriculitis; post-operative)
  • 10.Brain death or imminent death (within 24 hours)
  • 11.Pregnancy or nephrotic syndrome diagnosed patient
  • 12.DNR (do not resuscitate) orders

研究者

相似试验

The Effect of Early Correction of Serum Calcium and... | 临床试验